EsoGuard Clinical Trial

Do you have chronic heartburn?

Your acid reflux could be a sign of a more serious condition. Find out about a new test aiding in detection
of esophageal precancer and see if
you qualify for a clinical trial.

See if I qualify

Get tested.
Advance research.

About the Clinical Trial
The EsoGuard clinical trial aims to gather information about a new DNA test and the diagnosis of esophageal cancer and other precanerous conditions.
Your participation could impact how esophageal disease is detected for future generations.
See if I qualify
How it works
Complete the
questionaire

A clinical trial representative will
contact you to confirm details

Visit a clinic offering
the trial near you

Eligibility

Let's get started to see if this study is right for you.

Please fill out the following information and
answer the five short questions below.

    How many years have you had chronic GERD, acid reflux or heartburn?*
    1 Year2 YearsMore than 5 Years

    Do you have a family history of heartburn, Barrett's esophagus or esophageal cancer?*
    HeartburnBarrett's esophagusEsophageal cancerNone

    How would you describe yourself?*
    American Indian or Alaska NativeAsianBlack or African AmericanNative Hawaiian or Other Pacific IslanderWhite

    Are you overweight?*
    NoYes

    Do you use tobacco products or have you ever used tobacco products?*
    NoYes

    EsoGuard is a highly accurate test that detects altered DNA to help diagnose precursors to esophageal cancer.

    About the EsoGuard esophageal DNA test
    EsoGuard is a DNA test that detects abnormal esophageal cells, such as Barrett’s Esophagus, precancerous cells with dysplasia and cancer.
    How it works
    A physician performs a cell collection procedure to gather cells from your lower esophagus for analysis. The collected cells are shipped to our laboratory where the DNA is tested using the EsoGuard advanced molecular diagnostic test.
    More detailed information about the EsoGuard clinical trial is available here.

    REFERENCES: 

    1. Science Translational Medicine 17 Jan 2018: Vol. 10, Issue 424, eaao5848, DOI: 10.1126/scitranslmed.aao5848
    © 2021 Lucid Diagnostics Privacy Policy Terms of Use
    EsoGuard is a laboratory developed test available through a CLIA certified and CAP accredited laboratory.
    EsoGuard is a trademark of Lucid Diagnostics. AD-0361 RevA